Black Diamond Therapeutics, Inc. (BDTX)
3.00
+0.42
(+16.28%)
USD |
NASDAQ |
May 19, 16:00
2.94
-0.06
(-2.00%)
After-Hours: 20:00
Black Diamond Therapeutics Total Assets (Quarterly) : 132.92M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Editas Medicine, Inc. | 149.34M |
| IDEAYA Biosciences, Inc. | 1.030B |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.62M |
| Shareholders Equity (Quarterly) | 104.30M |
| Debt to Equity Ratio | 0.1714 |
| Current Ratio | 8.461 |
| Net Debt Paydown Yield | 0.71% |